Fentanyl
Back to searchMolecule Structure
Scientific Name
Fentanyl
Description of the Drug
Fentanyl is an opioid analgesic used in anesthesia, for breakthrough cancer pain, or round the clock pain management.
http://www.drugbank.ca/drugs/DB00813
Brand Name(s)
Abstral, Actiq, Breakyl, Duragesic, Duragesic-100, Duragesic-12, Duragesic-25, Duragesic-37, Duragesic-50, Duragesic-75, Durogesic, Durogesic dtrans, Effentora, Fencino, Fentalis reservoir, Fentanyl-100, Fentanyl-12, Fentanyl-25, Fentanyl-37, Fentanyl-50, Fentanyl-62, Fentanyl-75, Fentanyl-87, Fentora, Ionsys, Leptanal, Matrifen, Mezolar matrix, Mylafent, Opiodur, Oralet, Osmach, Osmanil, Pecfent, Recivit, Sublimaze, Subsys, Tilofyl, Victanyl, Yemex
Company Owner(s)
Watson Laboratories Inc, Fresenius Kabi Usa Llc, Actavis Laboratories Ut Inc Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc, Kindeva Drug Delivery Lp, Par Pharmaceutical Inc, Sentynl Therapeutics Inc, Mayne Pharma Llc, Biodelivery Sciences International Inc, Abbott Laboratories Hosp Products Div, Btcp Pharma Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Mu opioid receptor | SINGLE PROTEIN | AGONIST | CHEMBL233 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL8804 | |||||||||
| PharmGKB | PA449599 | |||||||||
| Human Metabolome Database | HMDB0014951 | |||||||||
| WDI | FENTANYL | |||||||||
| DrugBank | DB00813 | |||||||||
| PubChem: Thomson Pharma | 14753493 | |||||||||
| PubChem | 3345 | |||||||||
| Nikkaji | J5.736C | |||||||||
| PDBe | 7V7 | |||||||||
| BindingDB | 50008984 | |||||||||
| EPA CompTox Dashboard | DTXSID9023049 | |||||||||
| DrugCentral | 1164 | |||||||||
| Brenda | 229447 | 229448 | ||||||||
| Guide to Pharmacology | 1626 | |||||||||
| GSRS | e0319997-2726-4317-810a-0ec13ff9b4e1 | |||||||||
| rxnorm | FENTANYL | ABSTRAL | FENTANYL HYDROCHLORIDE | FENTANYL CITRATE | FENTORA | SUBSYS | DURAGESIC | IONSYS | LAZANDA | ACTIQ |
| ChEBI | 119915 | |||||||||
| ZINC | ZINC000002522669 |
